Naba Al Saha Medical Services Past Earnings Performance
Past criteria checks 1/6
Naba Al Saha Medical Services has been growing earnings at an average annual rate of 20.8%, while the Healthcare industry saw earnings growing at 20.3% annually. Revenues have been growing at an average rate of 32.4% per year. Naba Al Saha Medical Services's return on equity is 19.5%, and it has net margins of 19.1%.
Key information
20.8%
Earnings growth rate
-4.2%
EPS growth rate
| Healthcare Industry Growth | 12.3% |
| Revenue growth rate | 32.4% |
| Return on equity | 19.5% |
| Net Margin | 19.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Naba Al Saha Medical Services' (TADAWUL:9546) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Sep 07
Returns At Naba Al Saha Medical Services (TADAWUL:9546) Appear To Be Weighed Down
Aug 27We Ran A Stock Scan For Earnings Growth And Naba Al Saha Medical Services (TADAWUL:9546) Passed With Ease
Apr 02The Returns At Naba Al Saha Medical Services (TADAWUL:9546) Aren't Growing
Jan 17Revenue & Expenses Breakdown
How Naba Al Saha Medical Services makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 197 | 38 | 30 | 0 |
| 31 Mar 24 | 190 | 45 | 29 | 0 |
| 31 Dec 23 | 182 | 52 | 28 | 0 |
| 30 Sep 23 | 165 | 46 | 26 | 0 |
| 30 Jun 23 | 149 | 39 | 23 | 0 |
| 31 Mar 23 | 139 | 33 | 22 | 0 |
| 31 Dec 22 | 130 | 27 | 20 | 0 |
| 30 Sep 22 | 127 | 27 | 20 | 0 |
| 30 Jun 22 | 124 | 27 | 20 | 0 |
| 31 Mar 22 | 121 | 26 | 19 | 0 |
| 31 Dec 21 | 118 | 26 | 18 | 0 |
| 31 Dec 20 | 116 | 27 | 17 | 0 |
Quality Earnings: 9546 has a high level of non-cash earnings.
Growing Profit Margin: 9546's current net profit margins (19.1%) are lower than last year (26.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 9546's earnings have grown significantly by 20.8% per year over the past 5 years.
Accelerating Growth: 9546's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 9546 had negative earnings growth (-4.2%) over the past year, making it difficult to compare to the Healthcare industry average (15.7%).
Return on Equity
High ROE: 9546's Return on Equity (19.5%) is considered low.